Home » Topics » Conferences

Conferences
RSS

Santen characterizes dual NEP/ACE inhibitor

March 24, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

New antiinflammatory agent from Yakult Honsha

March 24, 1997

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

SA-7060: a dual NEP and ACE inhibitor from Santen

March 20, 1997

Sumitomo presents new Na+/H+-exchange inhibitor

March 20, 1997

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Agent for atopic dermatitis reported by Terumo

March 20, 1997

Highly potent and selective ETA antagonist from Tanabe Seiyaku

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...